Real-time enrollment status for this solid tumor cancer clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:07 PM UTC
| NCT Number | NCT07193511 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor Cancer |
| Phase | PHASE1 |
| Target Enrollment | 355 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Avenzo Therapeutics, Inc. |
| Last Updated on CT.gov | October 5, 2026 (2 weeks ago) |
As of October 21, 2026: Clinical trial NCT07193511 is currently recruiting participants. This phase1 study for solid tumor cancer is actively seeking new participants at 15 locations across the United States. The study is sponsored by Avenzo Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07193511 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07193511 was last updated 2 weeks ago (October 5, 2026). HelloStudys verifies this status automatically.